title: Peripheral leptin regulates bone formation.
abstract: Substantial evidence does not support the prevailing view that leptin, acting through a hypothalamic relay, decreases bone accrual by inhibiting bone formation. To clarify the mechanisms underlying regulation of bone architecture by leptin, we evaluated bone growth and turnover in wild-type (WT) mice, leptin receptor-deficient db/db mice, leptin-deficient ob/ob mice, and ob/ob mice treated with leptin. We also performed hypothalamic leptin gene therapy to determine the effect of elevated hypothalamic leptin levels on osteoblasts. Finally, to determine the effects of loss of peripheral leptin signaling on bone formation and energy metabolism, we used bone marrow (BM) from WT or db/db donor mice to reconstitute the hematopoietic and mesenchymal stem cell compartments in lethally irradiated WT recipient mice. Decreases in bone growth, osteoblast-lined bone perimeter and bone formation rate were observed in ob/ob mice and greatly increased in ob/ob mice following subcutaneous administration of leptin. Similarly, hypothalamic leptin gene therapy increased osteoblast-lined bone perimeter in ob/ob mice. In spite of normal osteoclast-lined bone perimeter, db/db mice exhibited a mild but generalized osteopetrotic-like (calcified cartilage encased by bone) skeletal phenotype and greatly reduced serum markers of bone turnover. Tracking studies and histology revealed quantitative replacement of BM cells following BM transplantation. WT mice engrafted with db/db BM did not differ in energy homeostasis from untreated WT mice or WT mice engrafted with WT BM. Bone formation in WT mice engrafted with WT BM did not differ from WT mice, whereas bone formation in WT mice engrafted with db/db cells did not differ from the low rates observed in untreated db/db mice. In summary, our results indicate that leptin, acting primarily through peripheral pathways, increases osteoblast number and activity.
authors.affiliation: Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, OR 97331, USA.
authors.forename: Russell T
authors.initials: RT
authors.lastname: Turner
authors.forename: Satya P
authors.initials: SP
authors.lastname: Kalra
authors.forename: Carmen P
authors.initials: CP
authors.lastname: Wong
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Philbrick
authors.forename: Laurence B
authors.initials: LB
authors.lastname: Lindenmaier
authors.forename: Stephane
authors.initials: S
authors.lastname: Boghossian
authors.forename: Urszula T
authors.initials: UT
authors.lastname: Iwaniec
mesh_terms: D052436:Adipose Tissue, White / Q000033:anatomy & histology / Q000187:drug effects; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D016026:Bone Marrow Transplantation; D001862:Bone Resorption / Q000378:metabolism / Q000473:pathology; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D015316:Genetic Therapy; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D020738:Leptin / Q000008:administration & dosage / Q000172:deficiency / Q000378:metabolism* / Q000494:pharmacology; D051379:Mice; D008954:Models, Biological; D009929:Organ Size / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects; D054411:Receptors, Leptin / Q000172:deficiency / Q000378:metabolism; D040521:Subcutaneous Tissue / Q000187:drug effects
chemical_list: D020738:Leptin; D054411:Receptors, Leptin; C515447:leptin receptor, mouse